Bank of Montreal’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,857
| Closed | -$405 | – | 4085 |
|
|
2022
Q2 | $405 | Buy |
4,857
+4,269
| +726% | +$331K | ﹤0.01% | 2818 |
|
|
2022
Q1 | $58K | Buy |
+588
| New | +$77.6K | ﹤0.01% | 3767 |
|
|
2021
Q4 | – | Sell |
-1,300
| Closed | -$330K | – | 3513 |
|
|
2021
Q3 | $330K | Sell |
1,300
-131
| -9% | -$37.4K | ﹤0.01% | 3082 |
|
|
2021
Q2 | $574K | Buy |
1,431
+97
| +7% | +$38.4K | ﹤0.01% | 2760 |
|
|
2021
Q1 | $499K | Buy |
1,334
+1,148
| +617% | +$565K | ﹤0.01% | 2641 |
|
|
2020
Q4 | $122K | Sell |
186
-210
| -53% | -$133K | ﹤0.01% | 3482 |
|
|
2020
Q3 | $287K | Sell |
396
-119
| -23% | -$92.8K | ﹤0.01% | 2573 |
|
|
2020
Q2 | $441K | Buy |
515
+79
| +18% | +$59.6K | ﹤0.01% | 2327 |
|
|
2020
Q1 | $240K | Sell |
436
-673
| -61% | -$656K | ﹤0.01% | 2260 |
|
|
2019
Q4 | $1.26M | Buy |
1,109
+365
| +49% | +$397K | ﹤0.01% | 2127 |
|
|
2019
Q3 | $886K | Sell |
744
-1,885
| -72% | -$2.88M | ﹤0.01% | 2134 |
|
|
2019
Q2 | $4.33M | Sell |
2,629
-626
| -19% | -$1.08M | ﹤0.01% | 1276 |
|
|
2019
Q1 | $6.63M | Buy |
3,255
+8
| +0.2% | +$14.1K | 0.01% | 1011 |
|
|
2018
Q4 | $4.17M | Buy |
3,247
+130
| +4% | +$199K | ﹤0.01% | 1173 |
|
|
2018
Q3 | $5.9M | Buy |
3,117
+833
| +36% | +$1.72M | ﹤0.01% | 1105 |
|
|
2018
Q2 | $4.64M | Buy |
2,284
+483
| +27% | +$1.1M | ﹤0.01% | 1207 |
|
|
2018
Q1 | $3.98M | Buy |
1,801
+1,724
| +2,239% | +$4.39M | ﹤0.01% | 1258 |
|
|
2017
Q4 | $176K | Sell |
77
-201
| -72% | -$408K | ﹤0.01% | 2733 |
|
|
2017
Q3 | $494K | Buy |
278
+149
| +116% | +$208K | ﹤0.01% | 2278 |
|
|
2017
Q2 | $176K | Buy |
129
+70
| +119% | +$84.5K | ﹤0.01% | 2716 |
|
|
2017
Q1 | $70K | Sell |
59
-100
| -63% | -$102K | ﹤0.01% | 2957 |
|
|
2016
Q4 | $124K | Buy |
159
+114
| +253% | +$90.5K | ﹤0.01% | 2727 |
|
|
2016
Q3 | $40K | Buy |
+45
| New | +$32.6K | ﹤0.01% | 3112 |
|
|
2016
Q2 | – | Sell |
-28
| Closed | -$15K | – | 4088 |
|
|
2016
Q1 | $15K | Sell |
28
-17
| -38% | -$10.4K | ﹤0.01% | 3488 |
|
|
2015
Q4 | $37K | Buy |
45
+4
| +10% | +$4K | ﹤0.01% | 3154 |
|
|
2015
Q3 | $46K | Sell |
41
-75
| -65% | -$137K | ﹤0.01% | 2952 |
|
|
2015
Q2 | $252K | Buy |
116
+19
| +20% | +$38.7K | ﹤0.01% | 2301 |
|
|
2015
Q1 | $152K | Sell |
97
-136
| -58% | -$179K | ﹤0.01% | 2463 |
|
|
2014
Q4 | $277K | Sell |
233
-446
| -66% | -$298K | ﹤0.01% | 2341 |
|
|
2014
Q3 | $315K | Buy |
679
+216
| +47% | +$99.7K | ﹤0.01% | 2315 |
|
|
2014
Q2 | $231K | Buy |
+463
| New | +$148K | ﹤0.01% | 2454 |
|
Other funds holding BLUE
TCM
BBA
CS
Bank of Montreal's BLUE Position: Q3 2022 in Review
Bank of Montreal sold out of bluebird bio (BLUE) in Q3 2022, closing a stake of 4,857 shares — an estimated $405 sold.
Bank of Montreal first reported a position in BLUE in Q2 2014 and held it in 31 quarters. The position peaked at $6.63M in Q1 2019. 162 funds tracked by Wall St. Rank hold BLUE as of Q3 2022.
- Bank of Montreal reported no remaining bluebird bio position as of Q3 2022 after selling out during the quarter.
- Bank of Montreal sold 4,857 bluebird bio shares in Q3 2022, an estimated $405.
- Bank of Montreal first reported a position in bluebird bio in Q2 2014 and held it in 31 quarters.
- Bank of Montreal's bluebird bio position peaked at $6.63M in Q1 2019.
- 162 funds tracked by Wall St. Rank held bluebird bio as of Q3 2022.
Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.